高级检索
当前位置: 首页 > 详情页

First Report in China of Enterobacteriaceae Clinical Isolates Coharboring blaNDM-1 and blaIMP-4 Drug Resistance Genes

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Lab Med, Wuhan 430030, Peoples R China
出处:
ISSN:

摘要:
Aims: To describe the identification of two carbapenem-resistant, NDM-1 and IMP-4, carbapenemases coproducing Enterobacteriaceae isolates recovered from hospitalized patients in China. Both Klebsiella pneumoniae clinical isolates (Kpn922 and Kpn9599) were resistant to meropenem and imipenem and were subjected to additional antibiotic susceptibility testing. Polymerase chain reaction (PCR) and sequence analyses were used to characterize bacterial carbapenemase resistance genes, extended-spectrum beta-lactamases, plasmid-mediated AmpC enzymes, quinolone resistance, and 16s RNA methylase. Genetic relatedness was determined using pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Plasmids were analyzed by S1-PFGE and Southern blot. Results: PCR analyses revealed that the Kpn922 isolate carried bla(NDM-1), bla(IMP-4), bla(TEM-1), and bla(SHV-1) genes, while Kpn9599 carried bla(NDM-1), bla(IMP-4), bla(TEM-1), and bla(SHV-12) genes. MLST determined that the two isolates were ST1043 and ST571 sequence types. Southern blot analyses revealed that metallo-beta-lactamase genes were plasmid borne in both isolates. Plasmids similar to 300 kb simultaneously carried bla(NDM-1) and bla(IMP-4). Conclusions: Coexistence of bla(NDM-1) and bla(IMP-4) in these clinical isolates may herald the emergence of a new pattern of drug resistance. Surveillance of carbapenemases, particularly metallo-beta-lactamases, in Enterobacteriaceae is urgently needed to control and prevent the spread of these resistance determinants in China.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 3 区 医学
小类 | 4 区 传染病学 4 区 微生物学 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 传染病学 4 区 微生物学 4 区 药学
JCR分区:
出版当年[2013]版:
Q2 MICROBIOLOGY Q2 PHARMACOLOGY & PHARMACY Q3 INFECTIOUS DISEASES
最新[2024]版:
Q3 INFECTIOUS DISEASES Q3 PHARMACOLOGY & PHARMACY Q4 MICROBIOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Lab Med, Wuhan 430030, Peoples R China
通讯作者:
通讯机构: [1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Lab Med, Wuhan 430030, Peoples R China [*1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Lab Med, 1095 Jiefang Ave, Wuhan 430030, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:898 今日访问量:0 总访问量:636 更新日期:2025-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)